Paediatric Respiratory Reviews
Volume 11, Issue 3 , Pages 154-157 , September 2010

Oxygen Titration Strategies in Chronic Neonatal Lung Disease

References 

  1. Avery M, Oppenheimer E. Recent increases in mortality from hyaline membrane disease. J Pediatr. 1960;57:553–559
  2. Silverman W. Retrolental Fibroplasia: A modern parable. New York: Grune & Stratton; 1980;
  3. Sauve RS, Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 1985;76:725–733
  4. Newth CJ, Gow RM, Rowe RD. The assessment of pulmonary arterial pressures in bronchopulmonary dysplasia by cardiac catheterization and M-mode echocardiography. Pediatr Pulmonol. 1985;1:58–62
  5. Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment. Archives of Disease in Childhood Fetal & Neonatal Edition. 1995;72:F14–F19
  6. STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. Pediatrics. 2000; 105:295–310.
  7. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-Saturation Targets and Outcomes in Extremely Preterm Infants. N Engl J Med. 2003;349:959–967
  8. Thilo E, Andersen D, Wasserstein M, Schmidt J, Luckey D. Saturation by pulse oximetry: comparison of the results obtained by instruments of different brands. J Pediatr. 1993;122:620–626
  9. Balfour-Lynn IM, Field DJ, Gringras P, Hicks B, Jardine E, Jones RC, et al. BTS guidelines for home oxygen in children. Thorax. 2009;64:ii1–26
  10. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr. 1988;112:67–72
  11. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman CM, Wiggins JW. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics. 1985;75:80–84
  12. Alpert BE, Gainey MA, Schidlow DV, Capitanio MA. Effect of oxygen on right ventricular performance evaluated by radionuclide angiography in two young patients with chronic lung disease. Pediatr Pulmonol. 1987;3:149–152
  13. Palmisano JM, Martin JM, Krauzowicz BA, Truman KH, Meliones JN. Effects of supplemental oxygen administration in an infant with pulmonary artery hypertension. Heart & Lung. 1990;19:627–630
  14. Baraldi E, Carra S, Vencato F, Filippone M, Trevisanuto D, Milanesi O, et al. Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study. Eur J Pediatr. 1997;156:878–882
  15. Weitzenblum E, Chaouat A. Hypoxic pulmonary hypertension in man: what minimum duration of hypoxaemia is required? Eur Respir J. 2001;18:251–253
  16. Moyer-Mileur LJ, Nielson DW, Pfeffer KD, Witte MK, Chapman DL. Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics. 1996;98:779–783
  17. Bass JL, Corwin M, Gozal D, Moore C, Nishida H, Parker S, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics. 2004;114:805–816
  18. Iles R, Edmunds A. Prediction of early outcome in resolving chronic lung disease of prematurity after discharge from hospital. Arch Dis Child. 1996;74:304–308
  19. Gray P, Rogers Y. Are infants with bronchopulmonary dysplasia at risk for sudden infant death syndrome?. Pediatrics. 1994;93:774–777
  20. Barash IA, Beatty C, Powell FL, Prisk GK, West JB. Nocturnal oxygen enrichment of room air at 3800 meter altitude improves sleep architecture. High Altitude Medicine & Biology. 2001;2:525–533
  21. Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2008;5:513–518
  22. Harris MA, Sullivan CE. Sleep pattern and supplementary oxygen requirements in infants with chronic neonatal lung disease. Lancet. 1995;345:831–832
  23. Fitzgerald D, Van Asperen P, Leslie G, Arnold J, Sullivan C. Higher SaO2 in chronic neonatal lung disease: does it improve sleep?. Pediatr Pulmonol. 1998;26:235–240
  24. Weinberger B, Laskin DL, Heck DE, Laskin JD. Oxygen toxicity in premature infants. Toxicology & Applied Pharmacology. 2002;181:60–67
  25. Jentzen J, Rockswold G, Anderson WR. Pulmonary oxygen toxic effect. Occurrence in a newborn infant despite low PaO2 due to an intracranial arteriovenous malformation. Archives of Pathology & Laboratory Medicine. 1984;108:334–337
  26. Murphy R, Driscoll P, O’Driscoll R. Emergency oxygen therapy for the COPD patient. Emerg Med J. 2001;18:333–339
  27. Robinson TD, Freiberg DB, Regnis JA, Young IH. The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease [see comment]. American Journal of Respiratory & Critical Care Medicine. 2000;161:1524–1529
  28. Chetta A, Aiello M, Foresi A, Marangio E, D’Ippolito R, Castagnaro A, et al. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasculitis & Diffuse Lung Diseases. 2001;18:170–175
  29. Buchdahl R, Bush A, Ward S, Cramer D. Pre-flight hypoxic challenge in infants and young children with respiratory disease. Thorax. 2004;59:1000
  30. British Thoracic Society Standards of Care Committee. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2002; 57:289–304.

PII: S1526-0542(09)00098-0

doi: 10.1016/j.prrv.2009.12.004

Paediatric Respiratory Reviews
Volume 11, Issue 3 , Pages 154-157 , September 2010

Article Tools

* Image Usage & Resolution